Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UK

Objective To report the outcomes of >1000 men with low‐risk prostate cancer treated with low‐dose‐rate ( LDR ) brachytherapy at three large UK cancer centres. Patients and Methods A total of 1038 patients with low‐risk prostate cancer (prostate‐specific antigen [ PSA ] ≤10 ng/mL, G leason score 6, ≤ T 2b disease) were treated with LDR iodine 125 ( I ‐125) brachytherapy between 2002 and 2007. Patients were treated at three UK centres. PSA and...